awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33628778-18D5A855-A20D-4E97-9AC1-521B781DDB41
Q33628778-18D5A855-A20D-4E97-9AC1-521B781DDB41
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33628778-18D5A855-A20D-4E97-9AC1-521B781DDB41
Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426.
P2860
Q33628778-18D5A855-A20D-4E97-9AC1-521B781DDB41
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33628778-18D5A855-A20D-4E97-9AC1-521B781DDB41
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0575939eba712e7896a547847332ce2e524e905e
P2860
Acquisition of resistance to antifolates caused by enhanced gamma-glutamyl hydrolase activity.